Determining clinically meaningful decline in preclinical Alzheimer disease
Objective To determine the time required for a preclinical Alzheimer disease population to
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
Determining clinically meaningful decline in preclinical Alzheimer disease
PS Insel, M Weiner, RS Mackin, E Mormino, YY Lim… - Neurology, 2019 - lup.lub.lu.se
OBJECTIVE: To determine the time required for a preclinical Alzheimer disease population
to decline in a meaningful way, use estimates of decline to update previous clinical trial …
to decline in a meaningful way, use estimates of decline to update previous clinical trial …
Determining clinically meaningful decline in preclinical Alzheimer disease
PS Insel, M Weiner, RS Mackin, E Mormino, YY Lim… - Neurology, 2019 - escholarship.org
ObjectiveTo determine the time required for a preclinical Alzheimer disease population to
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
[HTML][HTML] Determining clinically meaningful decline in preclinical Alzheimer disease
PS Insel, M Weiner, RS Mackin, E Mormino, YY Lim… - Neurology, 2019 - ncbi.nlm.nih.gov
Objective To determine the time required for a preclinical Alzheimer disease population to
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
[PDF][PDF] Determining clinically meaningful decline in preclinical Alzheimer disease
PS Insel, M Weiner, RS Mackin… - …, 2019 - minerva-access.unimelb.edu.au
Determining clinically meaningful decline in preclinical Alzheimer disease Page 1 ARTICLE
OPEN ACCESS Determining clinically meaningful decline in preclinical Alzheimer disease …
OPEN ACCESS Determining clinically meaningful decline in preclinical Alzheimer disease …
Determining clinically meaningful decline in preclinical Alzheimer disease
PS Insel, M Weiner, RS Mackin, E Mormino… - …, 2019 - portal.research.lu.se
OBJECTIVE: To determine the time required for a preclinical Alzheimer disease population
to decline in a meaningful way, use estimates of decline to update previous clinical trial …
to decline in a meaningful way, use estimates of decline to update previous clinical trial …
Determining clinically meaningful decline in preclinical Alzheimer disease.
PS Insel, M Weiner, RS Mackin, E Mormino, YY Lim… - Neurology, 2019 - psycnet.apa.org
Objective: To determine the time required for a preclinical Alzheimer disease population to
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
Determining clinically meaningful decline in preclinical Alzheimer disease.
PS Insel, M Weiner, RS Mackin, E Mormino, YY Lim… - Neurology, 2019 - europepmc.org
Objective To determine the time required for a preclinical Alzheimer disease population to
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
Determining clinically meaningful decline in preclinical Alzheimer disease
PS Insel, M Weiner, RS Mackin, E Mormino… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Objective To determine the time required for a preclinical Alzheimer disease population to
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
decline in a meaningful way, use estimates of decline to update previous clinical trial design …
[PDF][PDF] Determining clinically meaningful decline in preclinical Alzheimer disease
PS Insel, M Weiner, RS Mackin, E Mormino… - …, 2019 - research.monash.edu
Determining clinically meaningful decline in preclinical Alzheimer disease Page 1 ARTICLE
OPEN ACCESS Determining clinically meaningful decline in preclinical Alzheimer disease …
OPEN ACCESS Determining clinically meaningful decline in preclinical Alzheimer disease …